The head of the US FDA reiterated that the agency is applying a more skeptical approach to this year’s round of COVID-19 vaccine boosters.

Overall, CBT-I may be more effective than pharmacological therapies for improving sleep quality among patients with fibromyalgia.

Patients with vs without central sensitization syndrome had significantly more severe autonomic and sensory symptoms.

Disease activity during pregnancy remained stable among the majority of women with RA or SpA, though relapses requiring treatment intensification were not uncommon.

Despite medical innovations, maternal mortality rates in the US remain high, especially compared with those of similarly ...

Topline data were announced from 2 phase 3 trials evaluating MR-107A-02 for the treatment of moderate to severe acute pain.

Patients who are older and those who are of Hispanic ethnicity are more likely to demonstrate post-burn subjective visual complaints.

Phenotypic variables such as smoking history and occupational exposures were significators predictors of head and neck cancer risk.

Roughly 1 in 10 United States internal medicine physicians report a high degree of burnout, according to study findings.

Chronic migraine with or without aura was significantly associated with an increased risk for PPD, particularly in women with psychiatric and obstetric comorbidities.

The Food and Drug Administration has granted Fast Track designation to urcosimod for the treatment of neuropathic corneal pain.

The United States Food and Drug Administration has chosen Dr Vinay Prasad to lead its Center for Biologics Evaluation and Research.